X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
What ailed the key underperformers of 2009? - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • Dec 31, 2009

    What ailed the key underperformers of 2009?

    The rise in the stock markets post March 2009 is probably the sharpest we have seen in over a decade or so. The BSE-Sensex has risen by around 81% during the year. However, there were a few stocks that missed out on this rally. In this article, we have highlighted the top five stocks that underperformed the benchmark index.

    The list goes as follows - Reliance Communications (telecom), HUL (FMCG), NTPC (power), DLF (real estate) and Sun Pharmaceuticals (healthcare). The reasons for these stocks to have underperformed the overall markets are very subjective. These vary from poor results, to a turn of events in their respective industry, to an unfit balance sheet, amongst others.

    It must be noted that we have only highlighted stocks that form part of the BSE-Sensex. Also, we have only included the top loser/ underperformer of various sectors.

    Reliance Communications (Returns in - 2008: -70%, 2009: -24%)
    Giving a negative return of 24%, Reliance Communications (RCOM) was the top loser amongst stocks forming part of the BSE-Sensex during 2009. There are two key reasons for the same -its poor financial results and its issues with the DoT (Depart of Telecommunications). The reason for the former was a sharp decline in key operating parameters such as ARPUs and ARPMs, which were further hurt by its aggressive launch of GSM services. In a bid to woo customers, the company went out offering very attractive schemes, including free talk time. All these efforts had an adverse impact on the company's financials. During 1HFY10, revenues of its wireless business dropped by about 8% YoY. This segment forms around 60% of the company's revenues. The other key reason was of it being under the scanner of the Department of Telecommunication (DOT). The reason cited for the same is alleged under-reporting of revenues for FY07 and FY08.

    Data Source: CMIE Prowess, BSE


    Hindustan Unilever (Returns in - 2008: 17%, 2009: 6%)
    After a stellar performance in 2008 when Hindustan Unilever Limited (HUL) was one of the best performing stocks, the company disappointed investors in 2009. With gains of merely 6% YoY during the year, the company was one of the Sensex underperformers. The reason for this is not far to find. The company seems to have misjudged the preference of its consumers and ended up with the wrong strategy during the year. With rising raw material costs, the company increased the price of its products while shifting it's focused to premium products which were perceived to be recession proof. However, consumers in an effort to find value offerings either switched brands or down traded. This benefited HUL's competitors, who by taking a hit on margins after absorbing higher costs were able to gain market share. The result was HUL losing its customers and facing the daunting task of regaining its lost market share.

    Data Source: CMIE Prowess, BSE


    NTPC (Returns in - 2008: -28%, 2009: 30%)
    A 30% gain in a year is not bad. But when you compare it with peers and also the broader markets that gained about 81%, this seems petty. NTPC's stock has in fact not gone anywhere in the past two years. And investors must be ruing the lost opportunity. This is especially considering that all this while the company has been talking aloud of its mega growth plans. But not much seems to have fructified. Issues related to fuel - both coal and gas - continued to impact the company's growth plans in 2009. The same is likely to continue into 2010 as well. Further, the stock is already trading at fair valuations. This is not likely to make matters any good for investors.

    Data Source: CMIE Prowess, BSE


    DLF (Returns in - 2008: -74%, 2009: 28%)
    DLF continued to be in the rough patch during the early part of this year. The reasons for the same were various - tightening of liquidity, lower realisations, and lower demand. In addition, it had a lot of sorting out to do internally as well. The main issue was the huge debt on its books, which has increased by nearly one-third during FY09. However, the company decided to pull up its socks and restructure its books. In a bid to reduce the debt, it decided to sell its non-core assets. But these efforts seem to be going a bit slow as high interest costs have impacted the company's financials. However, the fact that the company was looking to restructure its books went down well with the investing community. This led to an almost 160% surge in the company's stock price from its lows in March this year. But as compared to the other index heavyweights and its peer group companies, DLF's stock performance over the last year has not been up to the mark.

    Data Source: CMIE Prowess, BSE


    Sun Pharmaceuticals (Returns in - 2008: -13%, 2009: 42%)
    Despite registering gains of 42% during 2009, Sun Pharma still managed to be part of the top 5 underperforming stocks of 2009. This underperformance could chiefly be attributed to the problems that its 76% subsidiary Caraco faced in the US. The USFDA found Caraco's manufacturing facility in Detroit to be non-compliant with good manufacturing practices and had seized certain drugs from this plant. This seriously impacted Caraco's business which in turn had a negative impact on Sun Pharma's performance as well. While efforts to resolve the problem are on, the timeline with respect to the same is anybody's guess as the Ranbaxy issue has shown. Barring the US, however, other businesses of Sun have been doing well and the company still enjoys among the best margins and return ratios in the pharma sector.

    Data Source: CMIE Prowess, BSE

     

     

    Equitymaster requests your view! Post a comment on "What ailed the key underperformers of 2009?". Click here!

      
     

    More Views on News

    How to Ride Alongside India's Best Fund Managers (The 5 Minute Wrapup)

    Jun 10, 2017

    Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.

    Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working (Vivek Kaul's Diary)

    Aug 21, 2017

    Most Indians who cannot find jobs, look at becoming self-employed.

    The Key Factor Pushing Gold Up These Days (Outside View)

    Aug 21, 2017

    PersonalFN explains the chief factor pushing gold prices up of late.

    How Unique Are the Companies You Invest In? (The 5 Minute Wrapup)

    Aug 21, 2017

    One of the hallmarks of successful investing is to look out for companies that have a unique and enduring moat.

    You've Heard of Timeless Books... Ever Heard of Timeless Stocks? (The 5 Minute Wrapup)

    Aug 19, 2017

    Ever heard of Lindy Effect? Find out how you can use it to pick timeless stocks.

    More Views on News

    Most Popular

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

    Aug 8, 2017

    'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    Bitcoin Continues Stellar Rise(Chart Of The Day)

    Aug 10, 2017

    Bitcoin hits an all-time high, is there more upside left?

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    S&P BSE SENSEX


    Aug 21, 2017 (Close)

    MARKET STATS